Structure

Physi-Chem Properties

Molecular Weight:  254.09
Volume:  267.538
LogP:  2.772
LogD:  2.871
LogS:  -4.401
# Rotatable Bonds:  2
TPSA:  35.53
# H-Bond Aceptor:  3
# H-Bond Donor:  0
# Rings:  3
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.824
Synthetic Accessibility Score:  2.439
Fsp3:  0.188
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.645
MDCK Permeability:  1.855772097769659e-05
Pgp-inhibitor:  0.916
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.014

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.419
Plasma Protein Binding (PPB):  94.63250732421875%
Volume Distribution (VD):  0.559
Pgp-substrate:  3.170912265777588%

ADMET: Metabolism

CYP1A2-inhibitor:  0.902
CYP1A2-substrate:  0.89
CYP2C19-inhibitor:  0.969
CYP2C19-substrate:  0.565
CYP2C9-inhibitor:  0.903
CYP2C9-substrate:  0.873
CYP2D6-inhibitor:  0.468
CYP2D6-substrate:  0.877
CYP3A4-inhibitor:  0.738
CYP3A4-substrate:  0.403

ADMET: Excretion

Clearance (CL):  8.025
Half-life (T1/2):  0.156

ADMET: Toxicity

hERG Blockers:  0.063
Human Hepatotoxicity (H-HT):  0.12
Drug-inuced Liver Injury (DILI):  0.91
AMES Toxicity:  0.745
Rat Oral Acute Toxicity:  0.323
Maximum Recommended Daily Dose:  0.051
Skin Sensitization:  0.167
Carcinogencity:  0.647
Eye Corrosion:  0.008
Eye Irritation:  0.919
Respiratory Toxicity:  0.787

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC228184

Natural Product ID:  NPC228184
Common Name*:   5-Methoxy-2-Phenyl-2,3-Dihydrochromen-4-One
IUPAC Name:   5-methoxy-2-phenyl-2,3-dihydrochromen-4-one
Synonyms:   5-Methoxyflavanone
Standard InCHIKey:  YLLFUILNISGLHO-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H14O3/c1-18-13-8-5-9-14-16(13)12(17)10-15(19-14)11-6-3-2-4-7-11/h2-9,15H,10H2,1H3
SMILES:  COc1cccc2c1C(=O)CC(O2)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL317869
PubChem CID:   147795
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002585] O-methylated flavonoids
          • [CHEMONTID:0002590] 5-O-methylated flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8300 Apis mellifera ligustica Species Apidae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens IC50 = 35700.0 nM PMID[454591]
NPT71 Cell Line HEK293 Homo sapiens FC = 3.6 n.a. PMID[454593]
NPT149 Individual Protein Endoplasmic reticulum-associated amyloid beta-peptide-binding protein Homo sapiens Potency = 31622.8 nM PMID[454594]
NPT48 Individual Protein Lysine-specific demethylase 4D-like Homo sapiens Potency = 31622.8 nM PMID[454594]
NPT151 Individual Protein 15-hydroxyprostaglandin dehydrogenase [NAD+] Homo sapiens Potency = 35481.3 nM PMID[454594]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 26608.6 nM PMID[454594]
NPT49 Individual Protein DNA-(apurinic or apyrimidinic site) lyase Homo sapiens Potency n.a. 5011.9 nM PMID[454594]
NPT29 Organism Rattus norvegicus Rattus norvegicus Protection = 32.0 % PMID[454592]
NPT94 Individual Protein Aldehyde dehydrogenase 1A1 Homo sapiens Potency = 25118.9 nM PMID[454594]
NPT2 Others Unspecified Potency = 14125.4 nM PMID[454594]
NPT2 Others Unspecified Inhibition = 108.3 % PMID[454595]
NPT27 Others Unspecified Activity <= 90.0 % PMID[454596]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC228184 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9597 High Similarity NPC41721
0.9535 High Similarity NPC99854
0.9389 High Similarity NPC259685
0.9308 High Similarity NPC125269
0.9248 High Similarity NPC329203
0.9248 High Similarity NPC310135
0.9248 High Similarity NPC150648
0.9248 High Similarity NPC265871
0.9248 High Similarity NPC225153
0.9248 High Similarity NPC274784
0.9248 High Similarity NPC222342
0.9248 High Similarity NPC20709
0.9248 High Similarity NPC11566
0.9231 High Similarity NPC292998
0.9225 High Similarity NPC278556
0.9225 High Similarity NPC284424
0.9179 High Similarity NPC188243
0.9179 High Similarity NPC472409
0.9179 High Similarity NPC6407
0.9179 High Similarity NPC110228
0.9167 High Similarity NPC254741
0.9154 High Similarity NPC473655
0.9154 High Similarity NPC101294
0.9113 High Similarity NPC314329
0.9111 High Similarity NPC22467
0.9111 High Similarity NPC4743
0.9111 High Similarity NPC324386
0.9111 High Similarity NPC213322
0.9111 High Similarity NPC312391
0.9104 High Similarity NPC140890
0.9098 High Similarity NPC287246
0.9098 High Similarity NPC476480
0.9098 High Similarity NPC13768
0.9098 High Similarity NPC296490
0.9098 High Similarity NPC79943
0.9098 High Similarity NPC32441
0.9098 High Similarity NPC107586
0.9098 High Similarity NPC84585
0.9098 High Similarity NPC295261
0.9098 High Similarity NPC12296
0.9098 High Similarity NPC243083
0.907 High Similarity NPC39753
0.907 High Similarity NPC115998
0.9062 High Similarity NPC475017
0.9044 High Similarity NPC147145
0.9044 High Similarity NPC324436
0.9044 High Similarity NPC194432
0.9044 High Similarity NPC223500
0.9044 High Similarity NPC324134
0.9044 High Similarity NPC265040
0.9044 High Similarity NPC66515
0.9044 High Similarity NPC37496
0.9044 High Similarity NPC182852
0.9044 High Similarity NPC306829
0.9044 High Similarity NPC228504
0.9044 High Similarity NPC1089
0.9044 High Similarity NPC125855
0.9044 High Similarity NPC227579
0.9044 High Similarity NPC296917
0.9044 High Similarity NPC40833
0.9044 High Similarity NPC64915
0.9044 High Similarity NPC166934
0.9044 High Similarity NPC76372
0.9044 High Similarity NPC161506
0.9044 High Similarity NPC148757
0.9044 High Similarity NPC167624
0.9044 High Similarity NPC107572
0.9044 High Similarity NPC220998
0.9044 High Similarity NPC76338
0.9044 High Similarity NPC78
0.9044 High Similarity NPC328164
0.9044 High Similarity NPC166482
0.9044 High Similarity NPC32739
0.9044 High Similarity NPC10937
0.9044 High Similarity NPC177354
0.9037 High Similarity NPC76445
0.9037 High Similarity NPC284550
0.9037 High Similarity NPC129853
0.903 High Similarity NPC118813
0.903 High Similarity NPC329225
0.903 High Similarity NPC99333
0.903 High Similarity NPC147686
0.903 High Similarity NPC280284
0.903 High Similarity NPC188947
0.903 High Similarity NPC472460
0.9023 High Similarity NPC161196
0.9008 High Similarity NPC182428
0.9 High Similarity NPC137264
0.8992 High Similarity NPC197425
0.8984 High Similarity NPC264428
0.8978 High Similarity NPC150408
0.8978 High Similarity NPC149026
0.8978 High Similarity NPC125894
0.8978 High Similarity NPC257097
0.8978 High Similarity NPC169591
0.8978 High Similarity NPC68104
0.8978 High Similarity NPC59522
0.8978 High Similarity NPC221432
0.8978 High Similarity NPC39329
0.8978 High Similarity NPC164980
0.8978 High Similarity NPC310130
0.8978 High Similarity NPC175504
0.8978 High Similarity NPC77794
0.8978 High Similarity NPC278249
0.8978 High Similarity NPC478086
0.8978 High Similarity NPC107177
0.8978 High Similarity NPC85162
0.8978 High Similarity NPC223812
0.8978 High Similarity NPC185276
0.8978 High Similarity NPC143896
0.8978 High Similarity NPC75049
0.8978 High Similarity NPC91560
0.8978 High Similarity NPC214166
0.8978 High Similarity NPC316816
0.8978 High Similarity NPC81697
0.8976 High Similarity NPC2771
0.8971 High Similarity NPC52576
0.8971 High Similarity NPC279650
0.8971 High Similarity NPC96408
0.8971 High Similarity NPC248372
0.8971 High Similarity NPC166689
0.8971 High Similarity NPC17170
0.8971 High Similarity NPC110038
0.8971 High Similarity NPC156190
0.8971 High Similarity NPC3188
0.8971 High Similarity NPC258630
0.8963 High Similarity NPC261234
0.8963 High Similarity NPC136095
0.8955 High Similarity NPC290291
0.8955 High Similarity NPC275055
0.8939 High Similarity NPC223354
0.8915 High Similarity NPC125887
0.8913 High Similarity NPC235217
0.8913 High Similarity NPC197252
0.8913 High Similarity NPC469764
0.8913 High Similarity NPC473015
0.8913 High Similarity NPC131568
0.8913 High Similarity NPC209040
0.8913 High Similarity NPC473014
0.8913 High Similarity NPC131579
0.8913 High Similarity NPC473013
0.8913 High Similarity NPC87486
0.8913 High Similarity NPC124780
0.8913 High Similarity NPC236766
0.8905 High Similarity NPC73028
0.8905 High Similarity NPC202981
0.8897 High Similarity NPC171094
0.8889 High Similarity NPC17848
0.8889 High Similarity NPC124269
0.8881 High Similarity NPC61546
0.8881 High Similarity NPC72452
0.8881 High Similarity NPC231772
0.8881 High Similarity NPC234133
0.8881 High Similarity NPC473887
0.8881 High Similarity NPC29353
0.8881 High Similarity NPC47815
0.8881 High Similarity NPC127447
0.8881 High Similarity NPC194281
0.8881 High Similarity NPC124784
0.8881 High Similarity NPC240593
0.8872 High Similarity NPC66705
0.8871 High Similarity NPC35744
0.8849 High Similarity NPC109183
0.8849 High Similarity NPC470131
0.8849 High Similarity NPC195621
0.8849 High Similarity NPC472629
0.8849 High Similarity NPC470647
0.8849 High Similarity NPC475052
0.8849 High Similarity NPC473078
0.8849 High Similarity NPC470132
0.8849 High Similarity NPC301276
0.8849 High Similarity NPC127059
0.8849 High Similarity NPC20488
0.8849 High Similarity NPC67805
0.8849 High Similarity NPC214774
0.8849 High Similarity NPC267375
0.8849 High Similarity NPC246948
0.8849 High Similarity NPC469758
0.8849 High Similarity NPC142405
0.8849 High Similarity NPC176229
0.8849 High Similarity NPC312973
0.8849 High Similarity NPC111786
0.8849 High Similarity NPC285630
0.8849 High Similarity NPC54577
0.8849 High Similarity NPC470134
0.8849 High Similarity NPC470133
0.8849 High Similarity NPC83357
0.8849 High Similarity NPC88964
0.8846 High Similarity NPC187907
0.8846 High Similarity NPC211120
0.8841 High Similarity NPC113770
0.8837 High Similarity NPC475496
0.8837 High Similarity NPC49852
0.8824 High Similarity NPC316480
0.8824 High Similarity NPC18260
0.8824 High Similarity NPC78913
0.8815 High Similarity NPC228661
0.8815 High Similarity NPC250266
0.8815 High Similarity NPC157855
0.8815 High Similarity NPC103001

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC228184 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9313 High Similarity NPD2796 Approved
0.9113 High Similarity NPD1547 Clinical (unspecified phase)
0.9098 High Similarity NPD1550 Clinical (unspecified phase)
0.9098 High Similarity NPD1552 Clinical (unspecified phase)
0.903 High Similarity NPD1549 Phase 2
0.8647 High Similarity NPD1240 Approved
0.8529 High Similarity NPD1510 Phase 2
0.8519 High Similarity NPD1607 Approved
0.8511 High Similarity NPD4378 Clinical (unspecified phase)
0.8511 High Similarity NPD5401 Approved
0.8485 Intermediate Similarity NPD6832 Phase 2
0.8483 Intermediate Similarity NPD1934 Approved
0.844 Intermediate Similarity NPD6799 Approved
0.8425 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8425 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8414 Intermediate Similarity NPD7411 Suspended
0.8394 Intermediate Similarity NPD3748 Approved
0.8392 Intermediate Similarity NPD5403 Approved
0.8367 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD1551 Phase 2
0.8299 Intermediate Similarity NPD7819 Suspended
0.8255 Intermediate Similarity NPD7075 Discontinued
0.8252 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8231 Intermediate Similarity NPD6801 Discontinued
0.8219 Intermediate Similarity NPD6599 Discontinued
0.8219 Intermediate Similarity NPD4380 Phase 2
0.8175 Intermediate Similarity NPD1933 Approved
0.8156 Intermediate Similarity NPD1243 Approved
0.8146 Intermediate Similarity NPD5494 Approved
0.8133 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8112 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8099 Intermediate Similarity NPD3750 Approved
0.8088 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.806 Intermediate Similarity NPD2798 Approved
0.8056 Intermediate Similarity NPD1511 Approved
0.8043 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD920 Approved
0.8 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD5402 Approved
0.8 Intermediate Similarity NPD3817 Phase 2
0.7985 Intermediate Similarity NPD3267 Approved
0.7985 Intermediate Similarity NPD1203 Approved
0.7985 Intermediate Similarity NPD3266 Approved
0.7972 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7956 Intermediate Similarity NPD2313 Discontinued
0.7953 Intermediate Similarity NPD1241 Discontinued
0.7947 Intermediate Similarity NPD7768 Phase 2
0.7945 Intermediate Similarity NPD1512 Approved
0.7935 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD6166 Phase 2
0.7935 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD2801 Approved
0.7926 Intermediate Similarity NPD1019 Discontinued
0.7902 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD9717 Approved
0.7857 Intermediate Similarity NPD6959 Discontinued
0.7852 Intermediate Similarity NPD2797 Approved
0.7842 Intermediate Similarity NPD4307 Phase 2
0.7829 Intermediate Similarity NPD3882 Suspended
0.7821 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.782 Intermediate Similarity NPD1610 Phase 2
0.7786 Intermediate Similarity NPD1548 Phase 1
0.7785 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3749 Approved
0.7762 Intermediate Similarity NPD2346 Discontinued
0.7746 Intermediate Similarity NPD2799 Discontinued
0.7746 Intermediate Similarity NPD7033 Discontinued
0.7736 Intermediate Similarity NPD7074 Phase 3
0.7708 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7698 Intermediate Similarity NPD3268 Approved
0.7698 Intermediate Similarity NPD1296 Phase 2
0.7692 Intermediate Similarity NPD6099 Approved
0.7692 Intermediate Similarity NPD6100 Approved
0.7681 Intermediate Similarity NPD4908 Phase 1
0.7673 Intermediate Similarity NPD7054 Approved
0.7669 Intermediate Similarity NPD17 Approved
0.7655 Intermediate Similarity NPD2654 Approved
0.7655 Intermediate Similarity NPD2800 Approved
0.764 Intermediate Similarity NPD6559 Discontinued
0.7639 Intermediate Similarity NPD2344 Approved
0.7635 Intermediate Similarity NPD4661 Approved
0.7635 Intermediate Similarity NPD4662 Approved
0.763 Intermediate Similarity NPD3972 Approved
0.7625 Intermediate Similarity NPD7472 Approved
0.7622 Intermediate Similarity NPD4308 Phase 3
0.7613 Intermediate Similarity NPD919 Approved
0.761 Intermediate Similarity NPD3818 Discontinued
0.7597 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD6797 Phase 2
0.7571 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD2935 Discontinued
0.7566 Intermediate Similarity NPD5889 Approved
0.7566 Intermediate Similarity NPD5890 Approved
0.7556 Intermediate Similarity NPD422 Phase 1
0.755 Intermediate Similarity NPD3226 Approved
0.7532 Intermediate Similarity NPD3926 Phase 2
0.7531 Intermediate Similarity NPD7251 Discontinued
0.7518 Intermediate Similarity NPD3225 Approved
0.7518 Intermediate Similarity NPD1876 Approved
0.7516 Intermediate Similarity NPD1247 Approved
0.75 Intermediate Similarity NPD1608 Approved
0.75 Intermediate Similarity NPD9493 Approved
0.7485 Intermediate Similarity NPD7808 Phase 3
0.7483 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD6651 Approved
0.7483 Intermediate Similarity NPD4628 Phase 3
0.7451 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD6798 Discontinued
0.7432 Intermediate Similarity NPD2309 Approved
0.7432 Intermediate Similarity NPD3295 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD4618 Approved
0.7413 Intermediate Similarity NPD5124 Phase 1
0.7413 Intermediate Similarity NPD4622 Approved
0.7403 Intermediate Similarity NPD6844 Discontinued
0.74 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD6585 Discontinued
0.7378 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7376 Intermediate Similarity NPD4625 Phase 3
0.7372 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD5953 Discontinued
0.7346 Intermediate Similarity NPD7286 Phase 2
0.7346 Intermediate Similarity NPD5844 Phase 1
0.7343 Intermediate Similarity NPD3140 Approved
0.7343 Intermediate Similarity NPD1613 Approved
0.7343 Intermediate Similarity NPD3142 Approved
0.7343 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD411 Approved
0.732 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7319 Intermediate Similarity NPD4749 Approved
0.731 Intermediate Similarity NPD5688 Approved
0.731 Intermediate Similarity NPD5689 Approved
0.7308 Intermediate Similarity NPD4288 Approved
0.7305 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD1201 Approved
0.7292 Intermediate Similarity NPD447 Suspended
0.7285 Intermediate Similarity NPD2534 Approved
0.7285 Intermediate Similarity NPD2532 Approved
0.7285 Intermediate Similarity NPD2533 Approved
0.7279 Intermediate Similarity NPD1471 Phase 3
0.7259 Intermediate Similarity NPD1894 Discontinued
0.725 Intermediate Similarity NPD6232 Discontinued
0.723 Intermediate Similarity NPD2897 Discontinued
0.7222 Intermediate Similarity NPD943 Approved
0.7222 Intermediate Similarity NPD7473 Discontinued
0.7203 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD3887 Approved
0.7197 Intermediate Similarity NPD5535 Approved
0.7183 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD1652 Phase 2
0.7179 Intermediate Similarity NPD6279 Approved
0.7179 Intermediate Similarity NPD6280 Approved
0.7172 Intermediate Similarity NPD6355 Discontinued
0.7165 Intermediate Similarity NPD9261 Approved
0.7153 Intermediate Similarity NPD6233 Phase 2
0.7152 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD4360 Phase 2
0.7151 Intermediate Similarity NPD4363 Phase 3
0.7143 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD9545 Approved
0.7113 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD2861 Phase 2
0.7108 Intermediate Similarity NPD6104 Discontinued
0.7097 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD1470 Approved
0.708 Intermediate Similarity NPD5585 Approved
0.708 Intermediate Similarity NPD1651 Approved
0.7077 Intermediate Similarity NPD290 Approved
0.7075 Intermediate Similarity NPD2200 Suspended
0.7073 Intermediate Similarity NPD3751 Discontinued
0.7073 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2403 Approved
0.7054 Intermediate Similarity NPD9697 Approved
0.7047 Intermediate Similarity NPD2353 Approved
0.7047 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD6808 Phase 2
0.7037 Intermediate Similarity NPD2557 Approved
0.7037 Intermediate Similarity NPD3787 Discontinued
0.7029 Intermediate Similarity NPD1778 Approved
0.7025 Intermediate Similarity NPD1465 Phase 2
0.7024 Intermediate Similarity NPD8313 Approved
0.7024 Intermediate Similarity NPD8312 Approved
0.702 Intermediate Similarity NPD7466 Approved
0.7013 Intermediate Similarity NPD6273 Approved
0.7 Intermediate Similarity NPD2424 Discontinued
0.6993 Remote Similarity NPD7213 Phase 3
0.6993 Remote Similarity NPD7212 Phase 2
0.6988 Remote Similarity NPD1729 Discontinued
0.698 Remote Similarity NPD4477 Approved
0.698 Remote Similarity NPD4476 Approved
0.6971 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6966 Remote Similarity NPD3764 Approved
0.6947 Remote Similarity NPD9263 Approved
0.6947 Remote Similarity NPD9264 Approved
0.6947 Remote Similarity NPD9267 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data